Literature DB >> 27807101

TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions.

Jaewon Min1, Jerry W Shay2.   

Abstract

Although single-nucleotide somatic mutations in the proximal promoter of the human telomerase reverse transcriptase (TERT) gene create novel consensus sequences for transcription factors that enhance TERT expression, the precise mechanism of how telomerase is reactivated in cancer cells remains poorly understood. In this issue, Akıncılar and colleagues identify a potential mechanism of TERT reactivation that is mediated by a novel long-range chromatin interaction between the TERT promoter on chromosome 5p and a 300-kb upstream region. This permits recruitment of the transcription factor GABPA in mutant TERT promoters but not in wild-type promoters. Cancer Discov; 6(11); 1212-4. ©2016 AACRSee related article by Akıncılar and colleagues, p. 1276. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27807101      PMCID: PMC5111399          DOI: 10.1158/2159-8290.CD-16-1050

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  10 in total

1.  Frequency of TERT promoter mutations in human cancers.

Authors:  João Vinagre; Ana Almeida; Helena Pópulo; Rui Batista; Joana Lyra; Vasco Pinto; Ricardo Coelho; Ricardo Celestino; Hugo Prazeres; Luis Lima; Miguel Melo; Adriana Gaspar da Rocha; Ana Preto; Patrícia Castro; Ligia Castro; Fernando Pardal; José Manuel Lopes; Lúcio Lara Santos; Rui Manuel Reis; José Cameselle-Teijeiro; Manuel Sobrinho-Simões; Jorge Lima; Valdemar Máximo; Paula Soares
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

2.  Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.

Authors:  Sumit Borah; Linghe Xi; Arthur J Zaug; Natasha M Powell; Garrett M Dancik; Scott B Cohen; James C Costello; Dan Theodorescu; Thomas R Cech
Journal:  Science       Date:  2015-02-05       Impact factor: 47.728

3.  Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.

Authors:  Robert J A Bell; H Tomas Rube; Alex Kreig; Andrew Mancini; Shaun D Fouse; Raman P Nagarajan; Serah Choi; Chibo Hong; Daniel He; Melike Pekmezci; John K Wiencke; Margaret R Wrensch; Susan M Chang; Kyle M Walsh; Sua Myong; Jun S Song; Joseph F Costello
Journal:  Science       Date:  2015-05-14       Impact factor: 47.728

4.  Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.

Authors:  Yinghui Li; Qi-Ling Zhou; Wenjie Sun; Prashant Chandrasekharan; Hui Shan Cheng; Zhe Ying; Manikandan Lakshmanan; Anandhkumar Raju; Daniel G Tenen; Shi-Yuan Cheng; Kai-Hsiang Chuang; Jun Li; Shyam Prabhakar; Mengfeng Li; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2015-09-21       Impact factor: 28.824

5.  TERT promoter mutations in familial and sporadic melanoma.

Authors:  Susanne Horn; Adina Figl; P Sivaramakrishna Rachakonda; Christine Fischer; Antje Sucker; Andreas Gast; Stephanie Kadel; Iris Moll; Eduardo Nagore; Kari Hemminki; Dirk Schadendorf; Rajiv Kumar
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

6.  Highly recurrent TERT promoter mutations in human melanoma.

Authors:  Franklin W Huang; Eran Hodis; Mary Jue Xu; Gregory V Kryukov; Lynda Chin; Levi A Garraway
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

7.  Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation.

Authors:  Semih Can Akıncılar; Ekta Khattar; Priscilla Li Shan Boon; Bilal Unal; Melissa Jane Fullwood; Vinay Tergaonkar
Journal:  Cancer Discov       Date:  2016-09-20       Impact factor: 39.397

Review 8.  Role of Telomeres and Telomerase in Aging and Cancer.

Authors:  Jerry W Shay
Journal:  Cancer Discov       Date:  2016-03-30       Impact factor: 39.397

9.  Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.

Authors:  Josh Lewis Stern; Dan Theodorescu; Bert Vogelstein; Nickolas Papadopoulos; Thomas R Cech
Journal:  Genes Dev       Date:  2015-10-29       Impact factor: 11.361

10.  A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression.

Authors:  Linghe Xi; Jens C Schmidt; Arthur J Zaug; Dante R Ascarrunz; Thomas R Cech
Journal:  Genome Biol       Date:  2015-11-10       Impact factor: 13.583

  10 in total
  9 in total

1.  Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism.

Authors:  Kunitoshi Chiba; Franziska K Lorbeer; A Hunter Shain; David T McSwiggen; Eva Schruf; Areum Oh; Jekwan Ryu; Xavier Darzacq; Boris C Bastian; Dirk Hockemeyer
Journal:  Science       Date:  2017-08-17       Impact factor: 47.728

2.  A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing.

Authors:  Sounak Gupta; Chad M Vanderbilt; Yun-Te Lin; Jamal K Benhamida; Achim A Jungbluth; Satshil Rana; Amir Momeni-Boroujeni; Jason C Chang; Tiffany Mcfarlane; Paulo Salazar; Kerry Mullaney; Sumit Middha; Ahmet Zehir; Anuradha Gopalan; Tejus A Bale; Ian Ganly; Maria E Arcila; Ryma Benayed; Michael F Berger; Marc Ladanyi; Snjezana Dogan
Journal:  J Mol Diagn       Date:  2020-12-05       Impact factor: 5.568

Review 3.  Toward urinary cell-free DNA-based treatment of urothelial carcinoma: a narrative review.

Authors:  Yujiro Hayashi; Kazutoshi Fujita
Journal:  Transl Androl Urol       Date:  2021-04

4.  Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma.

Authors:  Yujiro Hayashi; Kazutoshi Fujita; Kyosuke Matsuzaki; Makoto Matsushita; Norihiko Kawamura; Yoko Koh; Kosuke Nakano; Cong Wang; Yu Ishizuya; Yoshiyuki Yamamoto; Kentaro Jingushi; Taigo Kato; Atsunari Kawashima; Takeshi Ujike; Akira Nagahara; Motohide Uemura; Ryoichi Imamura; Tetsuya Takao; Shingo Takada; George J Netto; Norio Nonomura
Journal:  Cancer Sci       Date:  2019-04-07       Impact factor: 6.716

5.  Genome-wide screens identify specific drivers of mutant hTERT promoters.

Authors:  Raghuvaran Shanmugam; Mert Burak Ozturk; Joo-Leng Low; Semih Can Akincilar; Joelle Yi Heng Chua; Matan Thangavelu Thangavelu; Giridharan Periyasamy; Ramanuj DasGupta; Vinay Tergaonkar
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-18       Impact factor: 12.779

6.  Pan-Cancer Analysis of Clinical Relevance via Telomere Maintenance Mechanism.

Authors:  Ji-Yong Sung; Jae-Ho Cheong
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

Review 7.  Regulation of Gene Expression by Telomere Position Effect.

Authors:  Kyung-Ha Lee; Do-Yeon Kim; Wanil Kim
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

8.  Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer.

Authors:  Raquel Carrasco; Mercedes Ingelmo-Torres; Ascensión Gómez; Ramón Trullas; Fiorella L Roldán; Tarek Ajami; Davinia Moreno; Leonardo Rodríguez-Carunchio; Antonio Alcaraz; Laura Izquierdo; Lourdes Mengual
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

9.  Conversion of a Non-Cancer-Selective Promoter into a Cancer-Selective Promoter.

Authors:  Praveen Bhoopathi; Anjan K Pradhan; Amit Kumar; Santanu Maji; Padmanabhan Mannangatti; Xiaoyan Deng; Dipankar Bandyopadhyay; Devanand Sarkar; Xiang-Yang Wang; Joseph W Landry; Swadesh K Das; Luni Emdad; Paul B Fisher
Journal:  Cancers (Basel)       Date:  2022-03-15       Impact factor: 6.575

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.